Innovent Biologics Inc. (IVBXF) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Innovent Biologics Inc.

    OTC: IVBXF · Real-Time Price · USD
    12.72
    0.34 (2.75%)
    At close: Oct 03, 2025, 1:56 PM
    12.50
    -1.73%
    After-hours: Oct 02, 2025, 12:07 PM EDT

    Innovent Biologics Ratios and Metrics

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -547.41 -52.98 -20.21 -20.78
    PEG Ratio
    		 6.00 0.97 0.90 -0.13
    PS Ratio
    		 5.50 8.78 9.67 13.28
    PB Ratio
    		 3.95 4.35 4.10 5.49
    P/FCF Ratio
    		 -123.81 -44.07 -13.34 -14.64
    P/OCF Ratio
    		 40.25 368.45 -22.95 -28
    OCF/S Ratio
    		 0.14 0.02 -0.42 -0.47
    Debt / Equity Ratio
    		 0.22 0.29 0.30 0.24
    Quick Ratio
    		 2.16 2.78 2.88 3.35
    Current Ratio
    		 2.35 3.00 3.29 3.79
    Asset Turnover
    		 0.44 0.30 0.26 0.26
    Interest Coverage
    		 -11.17 -17.03 -30.71 -43.28
    Return on Equity
    		 -0.01 -0.08 -0.2 -0.26
    Return on Assets
    		 n/a -0.05 -0.12 -0.17
    Return on Invested Capital
    		 -0.05 -0.09 -0.21 -0.21
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.84 0.71 0.80 0.87
    Net Profit Margin
    		 -0.01 -0.17 -0.48 -0.64
    Pretax Profit Margin
    		 -0.01 -0.18 -0.48 -0.62
    Operating Profit Margin
    		 -0.08 -0.27 -0.69 -0.63
    FCF Margin
    		 -0.04 -0.2 -0.72 -0.91
    EBITDA Margin
    		 -0.05 -0.11 -0.38 -0.56

    Add to Watchlist